Your browser doesn't support javascript.
Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes.
Funck-Brentano, Christian; Salem, Joe-Elie; Nguyen, Lee S; Drici, Milou-Daniel; Roden, Dan M.
  • Funck-Brentano C; Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, INSERM, CIC Paris-Est (CIC-1901), Department of Pharmacology, 75013 Paris, France. Electronic address: christian.funck-brentano@aphp.fr.
  • Salem JE; Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, INSERM, CIC Paris-Est (CIC-1901), Department of Pharmacology, 75013 Paris, France.
  • Nguyen LS; Intensive Care Medicine department, Cochin University Hospital, AP-HP Centre, 75014 Paris, France.
  • Drici MD; Department of Pharmacology and Toxicology, PharmacoVigilance Centre, Hôpital de Cimiez, University of Nice Côte d'Azur Medical Centre, 06003, Nice, France.
  • Roden DM; Department of Medicine, Vanderbilt University Medical Centre, Nashville, TN, USA.
Arch Cardiovasc Dis ; 113(5): 367-368, 2020 05.
Article in English | MEDLINE | ID: covidwho-122415
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cardiovascular Diseases / Torsades de Pointes Type of study: Prognostic study Limits: Humans Language: English Journal: Arch Cardiovasc Dis Journal subject: Vascular Diseases / Cardiology Year: 2020 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cardiovascular Diseases / Torsades de Pointes Type of study: Prognostic study Limits: Humans Language: English Journal: Arch Cardiovasc Dis Journal subject: Vascular Diseases / Cardiology Year: 2020 Document Type: Article